Tsa Bophelo Pharma & MedTech Pty Ltd
PS24 venture addresses significant healthcare challenges in South Africa and BRICS nations, where chronic diseases like diabetes, hypertension, and HIV/AIDS are prevalent. These conditions demand consistent medication management, but systemic issues hinder effective care: 1. Limited Accessibility: Rural and underserved areas face obstacles in accessing healthcare facilities, with long distances, crowded clinics, and insufficient infrastructure delaying timely medication delivery. 2. Inefficiency and Long Wait Times: Urban systems often suffer from inefficiencies, overburdening staff and causing long wait times, leading to patient dissatisfaction. 3. Non-Adherence to Medication: The challenges result in missed doses or discontinued treatment, worsening health outcomes and increasing healthcare costs. 4. Data Management Issues: Inadequate monitoring of patient data complicates medication forecasting and inventory management. PS24 Value Proposition 1. Increased Accessibility: Deploying PS24 machines in hospitals, clinics, pharmacies, and community centers enhances access to medication, eliminating travel and wait time concerns. 2. Reduced Wait Times and Improved Efficiency: 3. Improved Medication Adherence: With easier access and reminders through the PS24 app, patients are more likely to follow their medication regimens. 4. Data-Driven Insights: PS24 machines collect data on medication dispensing, offering insights into patient behavior and trends to help healthcare providers respond proactively. Implementation Plan 1. Strategic Partnerships: Collaborating government ministries. 2. Site Selection: Targeting high-traffic urban areas and underserved rural communities based on patient density and proximity to healthcare facilities. 3. Leasing and Service Model: Offering PS24 machines on 5 or 7-year leases to healthcare facilities. 4. Maintenance and Support: A dedicated team will maintain and service the machines. 5. Continuous Improvement and Scaling: Feedback and expansion across South Africa and BRICS countries.
Platforms And End-to-End Solutions For Government And Public Administration
Digitalization of services and service ecosystems for citizens
Tsa Bophelo - PS24 Venture Has planned for a 5-year deployment strategy, in which it intends to deploy 500 PS24-Machines annually, for the next 5 years. This amounts to a total of 2500 machines deployed in a a coordinated manner across the BRICS economic bloc. For further information on the deployment strategy and timeline please see the following chapters under the respective documents; PS24 Project Proposal page 24-28(Heading: Project Implementation Strategy in the International market). PS24 Investor Memorandum page 10 (Heading: Growth Potential and Key Performance Indicators) https://drive.google.com/drive/folders/1-3y_1KuIWsb8pR9GYgRoPHpCReArFan5
Project Implementation Strategy in the International market) Also see the Investor Memorandum Subheading GTM Strategy (Go to market).
The Pharmaself 24 (PS24) offers unique advantages that address healthcare challenges in South Africa, BRICS nations, and broader African markets: 1. Automated and Secure Dispensing: PS24 automates chronic medication dispensing, reducing human error and ensuring patients receive the correct dosage. Secure PIN codes guarantee patient privacy and medication safety, surpassing traditional pharmacy models. 2. 24/7 Accessibility: PS24 offers continuous, round-the-clock access to medications, improving convenience for patients with busy schedules or those needing medications outside regular hours, enhancing adherence to treatment. 3. Integration with Healthcare Systems: PS24 integrates with healthcare systems and electronic health records (EHRs), enabling real-time updates on medication pickups, automatic refills, and seamless communication between healthcare providers and patients. 4. Scalability and Flexibility: The PS24's modular design allows it to be tailored to different healthcare settings, making it suitable for hospitals, clinics, and underserved communities with limited infrastructure. 5. Cost-Effective Solution: PS24 reduces pharmacy infrastructure needs and staff, offering a cost-effective solution. The leasing model lowers upfront costs, while automation minimizes operational expenses linked to errors and wait times. 6. Enhanced Data Collection: PS24 collects data on medication dispensing, adherence, and inventory, providing insights for better medication management, public health planning, and improving patient outcomes. 7. Improved Adherence and Satisfaction: PS24's accessibility leads to higher adherence rates, reducing missed doses. Automated reminders for pickups ensure patients follow their prescribed regimens, leading to better health outcomes. 8. Robust Security and Compliance: PS24’s tamper-proof and secure access features meet regulatory standards, reducing risks of medication theft and unauthorized access. 9. Environmental Efficiency: By automating processes, PS24 reduces the need for paper records and optimizes inventory management, reducing medication waste and promoting eco-friendly operations. 10. Support for Telemedicine: PS24 supports the growing telemedicine trend, enabling patients to receive medications remotely and offering future telehealth services through Tsa Bophelo's app, improving healthcare in remote areas. Through these advantages, PS24 transforms chronic medication management, benefiting healthcare providers, patients, and public health systems, and making it a vital solution for South Africa, BRICS nations, and beyond.
Please see a list of the awards, contributions and memberships of the founder in the PS24 Project Proposal page 29.
Dr. Botlenyana Ncholo (MBChB), a PhD candidate in Pharmaceutical Industry Management. The intellectual property of the PS24 belongs to the manufacturing company. Tsa Bophelo intends to file trademarks for the relevant names associated with the product within its jurisdiction.
